CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30

CHAMPIONS ONCOLOGY, INC.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026

$4.69−0.01 (-0.21%)

Close on Oct 19, 2026

Community

Notes and questions about Champions Oncology from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Champions Oncology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Sep 11, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CSBR.

Revenue growth6.7% · median -51.5%

Operating margin-1.7% · median -319.6%

Net margin-1.8% · median -395.2%

Advertisement
300 × 250